The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 03, 2015
Filed:
Nov. 16, 2012
Applicant:
Universite Victor Segalen-bordeaux 2, Bordeaux Cedex, FR;
Inventors:
Christine Leaute-Labreze, Le Haillan, FR;
Eric Dumas De La Roque, Villenave d'Ornon, FR;
Alain Taieb, Bordeaux, FR;
Jean-Benoit Thambo, Bordeaux, FR;
Assignees:
Universite de Bordeaux, Bordeaux, FR;
Centre Hospitalier Universitaire de Bordeaux, Talence, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/00 (2006.01); A61K 31/18 (2006.01); A61K 31/138 (2006.01); A61K 31/222 (2006.01); A61K 31/36 (2006.01); A61K 31/404 (2006.01); A61K 31/4045 (2006.01); A61K 31/4704 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
A61K 31/138 (2013.01); A61K 31/00 (2013.01); A61K 31/18 (2013.01); A61K 31/222 (2013.01); A61K 31/36 (2013.01); A61K 31/404 (2013.01); A61K 31/4045 (2013.01); A61K 31/4704 (2013.01); A61K 31/5377 (2013.01);
Abstract
The present technology relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present technology provides an alternative to the known compounds, e.g. corticosteroids, interferon or vincristine, generally used for the treatment of hemangiomas.